PER 0.00% 7.7¢ percheron therapeutics limited

Where others have failed will Atl1102 succeed ?, page-815

  1. 198 Posts.
    lightbulb Created with Sketch. 62
    Hey @samofdiving

    Great post! Do you mind explaining further what you mean that we don’t need to go through further P2-3 trials to get to market? To my knowledge I thought we needed to run Phase 2B ($27M cost) and Phase 3 before we could commercialise? Would love to understand further if that’s not the case!


 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.7¢
Change
0.000(0.00%)
Mkt cap ! $69.41M
Open High Low Value Volume
7.7¢ 7.9¢ 7.6¢ $148.9K 1.895M

Buyers (Bids)

No. Vol. Price($)
1 48919 7.7¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 70000 1
View Market Depth
Last trade - 15.59pm 03/05/2024 (20 minute delay) ?
Last
7.8¢
  Change
0.000 ( 2.63 %)
Open High Low Volume
7.7¢ 7.9¢ 7.7¢ 43057
Last updated 13.04pm 03/05/2024 ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.